Tag: <span>Lung cancer</span>

Home / Lung cancer
Artificial intelligence tool developed to predict risk of lung cancer
Post

Artificial intelligence tool developed to predict risk of lung cancer

by Massachusetts General Hospital Credit: CC0 Public Domain Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and 80 years of age with a significant history of smoking, or who currently smoke. Lung cancer screening...

Actinidia arguta (sarunashi) juice inhibits lung cancer in mice
Post

Actinidia arguta (sarunashi) juice inhibits lung cancer in mice

OKAYAMA UNIVERSITY IMAGE: IN A STUDY BY RESEARCHERS FROM OKAYAMA UNIVERSITY, ACTINIDIA ARGUTA (SARUNASHI) JUICE REDUCED TUMOR NODULES IN CARCINOGEN-EXPOSED MICE CREDIT: SAKAE ARIMOTO‑KOBAYASHI Lung cancer is the leading cause of death in Japan and across the globe. Among all the cancers, lung cancer has one of the lowest five-year survival rates. Smoking tobacco and...

New bacterial therapy approach to treat lung cancer
Post

New bacterial therapy approach to treat lung cancer

by Holly Evarts, Columbia University School of Engineering and Applied Science Fluorescence microscopy image of lung cancer cells stained with antibodies against proteins involved in cellular growth. Credit: Dhruba Deb/Columbia Engineering Lung cancer is the deadliest cancer in the United States and around the world. Many of the currently available therapies have been ineffective, leaving...

Ultrafine particles can change defense against lung cancer
Post

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez, Baylor College of Medicine nCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/d mice. Three-month-old Pts4d/d mice (C57BL/6 background) were exposed to sterile PBS or nCB (20 mg/ml in sterile PBS) 12 times over a period of 1 month and euthanized after an additional month. i.n., intranasal...

Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer
Post

Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer

by European Organisation for Research and Treatment of Cancer  Credit: Pixabay/CC0 Public Domain Preliminary data from a phase I clinical trial of a new drug called NVL-520 for patients with non-small cell lung cancer (NSCLC) and other solid tumors, suggest that it may have the potential to both halt tumor growth by inhibiting a cancer-causing...

New therapeutic target against the most common lung cancer
Post

New therapeutic target against the most common lung cancer

UNIVERSITY OF BARCELONA IMAGE: FROM LEFT TO RIGHT: MARSELINA ARSHAKYAN, ELBA MARÍN (FRONT), PAULA DUCH, CRISTINA TEIXIDÓ, NOEMÍ REGUART, RAFAEL IKEMORI, JORDI ALCARAZ, MARTA GABASA AND NATALIA DÍAZ. CREDIT: UNIVERSITY OF BARCELONA The TIMP-1 protein levels in both tissues and blood have been repeatedly associated with a poor prognosis in lung cancers, but its role...

The obesity paradox in lung cancer diagnosis may differ by race
Post

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart, Thomas Jefferson University Credit: Pixabay/CC0 Public Domain Lung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates simultaneously rising, researchers have investigated the connections between cancer risk and body mass index (BMI). Unlike most other cancer types, where higher BMI is...

Vancouver researchers suggest air pollution be included as risk factor for patients with lung cancer and have never smoked
Post

Vancouver researchers suggest air pollution be included as risk factor for patients with lung cancer and have never smoked

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER IMAGE: RENELLE MYERS, BC CANCER, IN VANCOUVER, B.C. CREDIT: RENELLE MYERS, BC CANCER, IN VANCOUVER, B.C. (Vienna—August 9, 2022, 10:10 a.m. CEST)– Researchers from Vancouver, British Columbia examine the effect of duration of past exposure to air pollution with lung cancer diagnosis.    In 2013, the International Agency...

Post

BLOOD TEST MAY IMPROVE LUNG CANCER SCREENING

Annual screenings of patients at high risk for lung cancer can catch tumors early and improve a patient’s long-term prognosis. However, low-dose computer tomography (LDCT) has a high false-positive rate that can lead to unnecessary biopsies. The researchers found a biomarker in the blood that can complement LDCT by distinguishing non-small-cell lung cancer (NSCLC) from benign nodules...

Post

Blood test may help determine if nodules detected by CT scans are lung cancer

UNIVERSITY OF MISSOURI-COLUMBIA Annual screenings of patients at high risk for lung cancer can catch tumors early and improve a patient’s long-term prognosis. However, low-dose computer tomography (LDCT) has a high false-positive rate that can lead to unnecessary biopsies. University of Missouri School of Medicine researchers have found a biomarker in the blood that can...